Third Harmonic Bio Inc (THRD)
11.64
+0.51
(+4.58%)
USD |
NASDAQ |
Dec 04, 16:00
11.02
-0.62
(-5.33%)
After-Hours: 20:00
Third Harmonic Bio Enterprise Value: 205.41M for Dec. 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| December 03, 2024 | 205.41M |
| December 02, 2024 | 263.53M |
| November 29, 2024 | 278.85M |
| November 27, 2024 | 294.62M |
| November 26, 2024 | 286.51M |
| November 25, 2024 | 264.43M |
| November 22, 2024 | 265.79M |
| November 21, 2024 | 219.83M |
| November 20, 2024 | 227.49M |
| November 19, 2024 | 265.33M |
| November 18, 2024 | 222.08M |
| November 15, 2024 | 251.37M |
| November 14, 2024 | 285.16M |
| November 13, 2024 | 345.54M |
| November 12, 2024 | 381.59M |
| November 11, 2024 | 397.81M |
| November 08, 2024 | 379.78M |
| November 07, 2024 | 331.57M |
| November 06, 2024 | 301.83M |
| November 05, 2024 | 263.53M |
| November 04, 2024 | 249.34M |
| November 01, 2024 | 349.59M |
| October 31, 2024 | 320.76M |
| October 30, 2024 | 338.66M |
| October 29, 2024 | 356.10M |
| Date | Value |
|---|---|
| October 28, 2024 | 352.52M |
| October 25, 2024 | 292.14M |
| October 24, 2024 | 288.56M |
| October 23, 2024 | 283.64M |
| October 22, 2024 | 302.87M |
| October 21, 2024 | 295.71M |
| October 18, 2024 | 306.00M |
| October 17, 2024 | 290.35M |
| October 16, 2024 | 315.40M |
| October 15, 2024 | 280.95M |
| October 14, 2024 | 272.90M |
| October 11, 2024 | 262.16M |
| October 10, 2024 | 250.53M |
| October 09, 2024 | 254.56M |
| October 08, 2024 | 259.48M |
| October 07, 2024 | 254.56M |
| October 04, 2024 | 263.95M |
| October 03, 2024 | 258.14M |
| October 02, 2024 | 267.98M |
| October 01, 2024 | 287.21M |
| September 30, 2024 | 310.03M |
| September 27, 2024 | 299.49M |
| September 26, 2024 | 292.29M |
| September 25, 2024 | 299.07M |
| September 24, 2024 | 319.62M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-137.34M
Minimum
Dec 20 2022
691.02M
Maximum
Sep 27 2022
125.34M
Average
117.94M
Median
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.076M |
| Palatin Technologies Inc | 18.73M |
| iBio Inc | 13.68M |
| Theriva Biologics Inc | -12.63M |
| Oragenics Inc | 2.82M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -13.80M |
| Total Expenses (Quarterly) | 17.07M |
| EPS Diluted (Quarterly) | -0.33 |
| Earnings Yield | -8.25% |